Sign in

CIK 0001810182 · Non-accelerated filer<br>Smaller reporting company

ALX ONCOLOGY HOLDINGS INC

Sign in to watch
Ticker
ALXO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
850642577
Phone
650-466-7125
Business address
323 ALLERTON AVENUE, SOUTH SAN FRANCISCO, CA, 94080
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 3 Insider Initial Statement of Ownership
  4. 4 Derivatives Options or other derivatives
  5. 3 Insider Initial Statement of Ownership
  6. 4 Derivatives Options or other derivatives
  7. 3 Insider Initial Statement of Ownership
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 8-K Event Executive or director change · Regulation FD disclosure · Other events
  13. 8-K Event Executive or director change
  14. S-8 Other Securities Offered to Employees in Benefit Plans
  15. 4 Open-market sale Interim CFO sold 2,221 shares at $1.80 ($3,998)
  16. 4 Open-market sale Interim CFO sold 1,426 shares at $1.58 ($2,253)
  17. 4 Open-market sale PRESIDENT & CSO sold 10,796 shares at $1.58 ($17,060)
  18. SC TO-I/A Deal Tender Offer Statement by Issuer
  19. SCHEDULE 13G Stake Statement of Beneficial Ownership
  20. SCHEDULE 13G/A Stake Statement of Beneficial Ownership

Page 6 of 22 · 421 filings